New drug BI 425809 passes early safety check in healthy asian men
NCT ID NCT02383888
First seen Apr 04, 2026 · Last updated May 18, 2026 · Updated 5 times
Summary
This early-stage study tested a new drug called BI 425809 in 49 healthy Japanese and Chinese men. The main goal was to check safety and how the drug moves through the body after a single dose. No treatment for any disease was given; this was purely a safety and drug-level study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
1346.4.82001 Boehringer Ingelheim Investigational Site
Busan, South Korea
Conditions
Explore the condition pages connected to this study.